Meanwhile, anti-CD93 mAb was reported to stabilize vasculatures in animal models of pancreatic cancer and malignant melanoma to facilitate therapy responses for immunotherapeutic as well as chemotherapy (2021; Sun et al. 2021b). Here, CD93 is linked to familial pancreatic carcinoma.